ClinicalTrials.gov
public full text
Public Domain
PRevention Using EPA Against coloREctal Cancer
This research study is evaluating the effect of AMR101 as a possible chemopreventive agent to reduce risk of colorectal cancer in individuals with a history of colorectal adenoma. \- The name of the study drug involved in this study is: \-- AMR101 (VASCEPA).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment#1072314
- Cancer Screening and Prevention Program for High Risk Women#1073181
- W912UM09C0007 — SK ECOPLANT CO., LTD — Department of Defense ($754,451,897)#605571
- Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy#860412
- Open-label Extension Study of ADP101#1372958
Record · ID 1362478
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive